Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  allopurinol
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 90 for your search:
Start Over
Phase IV Randomized Study of Rasburicase Alone Versus Rasburicase and Allopurinol Versus Allopurinol Alone in Patients With Leukemia, Lymphoma, or Solid Tumor Malignancy at Risk for Hyperuricemia and Tumor Lysis Syndrome
Phase: Phase IV
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PROLOGUE-EFC4978, UCLA-0403071-01, NCT00230178
Phase II/III Consolidation Chemotherapy with VP-16/AMSA/AZC Following Induction with DNM/ARA-C/TG for Adult Primary or Secondary Leukemia
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: NCI-D82-051-605
Phase II/III Pilot Combination Chemotherapy and Radiotherapy for Previously Untreated Childhood ALL with Poor Prognosis
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 21
Sponsor: NCI
Protocol IDs: CCG-192P
Phase II/III Randomized Study of Standard-Dose vs High-Dose MTX Followed by Induction and Continuation for Patients with ALL or AUL
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: DFCI-81001, NCI-D82-018-0400, D82-018-0400
Phase III Pilot Intensification with High-Dose ARA-C and Consolidation with MACHO (CTX/ADR/VCR/PRED/MTX/L-ASP) for Adult ALL
Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: NCI
Protocol IDs: EST-2483
Phase III Chemotherapy with 5-FU and Allopurinol vs 5-FU Alone for Previously Untreated Metastatic Colorectal Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-GI-82389
Phase III Intensive Reinduction Followed by Intensive Maintenance vs Conventional Maintenance Chemotherapy in Relapsed Childhood ALL and AUL
Phase: Phase III
Type: Treatment
Status: Closed
Age: 21 and under
Sponsor: NCI
Protocol IDs: NCI-82-C-199, NCI-POB-7709, NCI-T83-0966N, T83-0966
Phase III Total Sanctuary vs Conventional CNS Treatment for Newly Diagnosed Acute Lymphoblastic Leukemia
Phase: Phase III
Type: Treatment
Status: Completed
Age: under 21
Sponsor: NCI
Protocol IDs: CCG-191, NCI-82-C-200, NCI-POB-7702
Phase III Radiotherapy Alone or in Combination with MOPP (NM/VCR/PCB/PRED) or MLMOPP (MOPP plus MTX/CF) for Hodgkin's Disease
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UCCRC-2121B, NCI-V83-0124
Phase III Chemotherapy with High-Dose ARA-C/AMSA and Low-Dose ARA-C for Maintenance vs No Maintenance Therapy for Adult ANLL
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to physiologic 70
Sponsor: NCI
Protocol IDs: EST-5483
Phase III Induction and Consolidation with ARA-C/DNM for Patients Over 50 Years of Age with Acute Nonlymphocytic Leukemia
Phase: Phase III
Type: Treatment
Status: Closed
Age: over 50
Sponsor:
Protocol IDs: UCSF-ANL-03, NCI-V85-0175
Phase III Randomized Comparison of CTX vs CTX plus Alpha-2 IFN in Previously Untreated Adults with Stage III/IV Low-Grade Follicular NHL
Phase: Phase III
Type: Treatment
Status: Completed
Age: over 15
Sponsor: NCI
Protocol IDs: CLB-8691, EST-7486, CALGB-8691
Start Over